quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:07·22d
SECFiling
Zivo Bioscience Inc. logo

SEC Form EFFECT filed by Zivo Bioscience Inc.

ZIVO· Zivo Bioscience Inc.
Health Care
Original source

Companies

  • ZIVO
    Zivo Bioscience Inc.
    Health Care

Recent analyst ratings

  • Dec 15UpdateMaxim Group$9.00

Related

  • PR18d
    ZIVO Bioscience Secures Commercial-Scale Manufacturing Agreement with Cyanotech Corporation for Zivolife™ Algal Biomass
  • SEC25d
    Zivo Bioscience Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
  • PR27d
    ZIVO Bioscience Provides Special Letter to Shareholders
  • INSIDER51d
    Director Yaldoo Laith L bought $14,998 worth of shares (1,543 units at $9.72) (SEC Form 4)
  • SEC55d
    Amendment: SEC Form SCHEDULE 13D/A filed by Zivo Bioscience Inc.
  • INSIDER66d
    Large owner Strome Mark E bought $195,400 worth of shares (20,000 units at $9.77) (SEC Form 4)
  • INSIDER71d
    Director Yaldoo Laith L bought $24,997 worth of shares (2,434 units at $10.27) (SEC Form 4)
  • INSIDER85d
    Director Cornell Alison A bought $99,995 worth of shares (11,709 units at $8.54), increasing direct ownership by 4% to 279,481 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022